Item Type | Name |
Academic Article
|
Management of breast carcinoma identified intraoperatively during reduction mammaplasty.
|
Academic Article
|
Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
|
Academic Article
|
Determining the optimal approach to breast reconstruction after partial mastectomy.
|
Academic Article
|
The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.
|
Academic Article
|
Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy.
|
Academic Article
|
Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
|
Academic Article
|
Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
|
Concept
|
Carcinoma, Ductal
|
Concept
|
Carcinoma, Ductal, Breast
|
Academic Article
|
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.
|
Academic Article
|
Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
|
Academic Article
|
Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.
|
Academic Article
|
Histologic localization of sentinel lymph node metastases in breast cancer.
|
Academic Article
|
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
|
Academic Article
|
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
|
Academic Article
|
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
|
Academic Article
|
Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
|
Academic Article
|
Imaging differences in metaplastic and invasive ductal carcinomas of the breast.
|
Academic Article
|
Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.
|
Academic Article
|
Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics.
|
Academic Article
|
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
|
Academic Article
|
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
|
Academic Article
|
Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.
|
Academic Article
|
Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
|
Academic Article
|
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
|
Academic Article
|
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
|
Academic Article
|
Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
|
Academic Article
|
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
|
Academic Article
|
Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer.
|
Academic Article
|
Pleomorphic ductal carcinoma of the breast: predictors of decreased overall survival.
|
Academic Article
|
Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin.
|
Academic Article
|
Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.
|
Academic Article
|
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.
|
Academic Article
|
Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
|
Academic Article
|
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.
|
Academic Article
|
Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.
|
Academic Article
|
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
|
Academic Article
|
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
|
Academic Article
|
Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
|
Academic Article
|
Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
|
Academic Article
|
Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma.
|
Academic Article
|
Cyclin E deregulation is an early event in the development of breast cancer.
|
Academic Article
|
Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.
|
Academic Article
|
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
|
Academic Article
|
Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death.
|
Academic Article
|
Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.
|
Academic Article
|
Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
|
Academic Article
|
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
|
Academic Article
|
American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.
|
Academic Article
|
Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.
|
Academic Article
|
Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
|
Academic Article
|
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
|
Academic Article
|
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients.
|
Academic Article
|
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
|
Academic Article
|
Breast-conservation therapy in early-stage breast cancer patients with a positive family history.
|
Academic Article
|
Does blue dye contribute to success of sentinel node mapping for breast cancer?
|
Academic Article
|
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
|
Academic Article
|
The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast.
|
Academic Article
|
Timing of surgical intervention for the intact primary in stage IV breast cancer patients.
|
Academic Article
|
Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.
|
Academic Article
|
Which threshold for ER positivity? a retrospective study based on 9639 patients.
|
Academic Article
|
Predicting the extent of nodal disease in early-stage breast cancer.
|
Academic Article
|
Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.
|
Academic Article
|
Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial.
|
Academic Article
|
Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.
|
Academic Article
|
Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
|
Academic Article
|
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
|
Academic Article
|
Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment.
|
Academic Article
|
Optimizing Mammography Screening Intervals.
|
Academic Article
|
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
|
Academic Article
|
A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072.
|
Academic Article
|
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
|
Academic Article
|
Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy.
|
Academic Article
|
Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
|
Academic Article
|
Ductal Carcinoma In Situ and Margins <2?mm: Contemporary Outcomes With Breast Conservation.
|
Academic Article
|
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
|
Academic Article
|
Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.
|